Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of fermagate vs lanthanum carbonate and placebo in hemodialysis patients with hyperphosphatemia
2008-004729-41Phase 3Completed
- Sponsor
- INEOS
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fermagate in hyperphosphatemia (4 arms), sponsored by INEOS. Primary endpoint: Stage 1 primary endpoint. Started Dec 2008; status: completed.
02
Drugs
fermagate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2008-004729-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004729-41.